From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006–2025) - Summary - MDSpire

Analyzing the Research Landscape of Neutrophil Extracellular Traps and Lung Diseases: A Bibliometric Study from 2006 to 2025

  • By

  • Yingqi Pan

  • Gang Liu

  • Hui Wang

  • Jie Zhu

  • Jiabing Tong

  • Zegeng Li

  • Qinjun Yang

  • June 3, 2026

Share

Objective:

To examine the research landscape and development sequence of neutrophil extracellular traps (NETs) in pulmonary diseases using bibliometric methods.

Key Findings:
  • 1,539 articles from 561 journals were analyzed.
  • Research has seen phased growth since 2006, with a peak in 2022 influenced by COVID-19.
  • China and the United States are the leading contributors.
  • Mark R. Looney is identified as the core author.
  • 'Frontiers in Immunology' is the most frequently cited journal.
  • Research focus has shifted from fundamental mechanisms to topics like pulmonary inflammation, immune thrombosis, and biomarkers.
Interpretation:

Remove this section.

Limitations:
  • The study is limited to articles indexed in specific databases (WoSCC and Scopus).
  • The bibliometric analysis may not capture all relevant literature outside these databases.
Conclusion:

Revise to eliminate unsupported claims and focus on findings.

Original Source(s)

From immunological mechanisms to targeted therapies: a bibliometric analysis in the domain of research concerning neutrophil extracellular traps and pulmonary diseases (2006–2025)

  • by Yingqi Pan, Gang Liu, Hui Wang, Jie Zhu, Jiabing Tong, Zegeng Li, Qinjun Yang

  • June 3, 2026

Related Content

Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non–small cell lung cancer: the RECAPC multicenter registry

Pathogen patterns in viral ARDS on V-V ECMO: a single-center experience

Same-Day COVID, Flu Vaccination Appears Safe

Study found no increased 90-day risk of serious adverse events with coadministration compared with vaccination alone.